Integer (NYSE:ITGR) Insider Kirk Thor Sells 19,773 Shares

Integer Holdings Corporation (NYSE:ITGR) insider Kirk Thor sold 19,773 shares of Integer stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $126.25, for a total value of $2,496,341.25. Following the completion of the sale, the insider directly owned 18,920 shares in the company, valued at approximately $2,388,650. The trade was a 51.10% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Integer Price Performance

Shares of NYSE ITGR traded up $0.01 during midday trading on Wednesday, reaching $126.22. 1,124,095 shares of the stock traded hands, compared to its average volume of 707,592. The company’s 50 day moving average is $116.25 and its 200 day moving average is $98.19. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $126.79. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41. The stock has a market capitalization of $4.29 billion, a PE ratio of 34.49, a P/E/G ratio of 2.40 and a beta of 0.62.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. During the same quarter in the previous year, the business posted $1.55 earnings per share. Integer’s quarterly revenue was down 2.6% on a year-over-year basis. On average, equities research analysts anticipate that Integer Holdings Corporation will post 6.09 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have recently issued reports on ITGR shares. Benchmark cut shares of Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. KeyCorp lowered Integer from an “overweight” rating to a “sector weight” rating in a research report on Monday, August 3rd. Raymond James Financial cut Integer from a “moderate buy” rating to a “hold” rating in a research note on Monday, August 3rd. Zacks Research upgraded Integer from a “strong sell” rating to a “hold” rating in a research report on Monday, July 20th. Finally, Piper Sandler cut Integer from an “overweight” rating to a “hold” rating and set a $127.00 target price for the company. in a report on Monday, August 3rd. One research analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $109.86.

Institutional Investors Weigh In On Integer

Several hedge funds and other institutional investors have recently modified their holdings of the business. Heartland Advisors Inc. boosted its holdings in Integer by 506.8% during the 4th quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock valued at $19,036,000 after acquiring an additional 202,715 shares during the period. WINTON GROUP Ltd purchased a new stake in Integer in the fourth quarter worth $4,836,000. William Blair Investment Management LLC lifted its position in shares of Integer by 70.1% during the fourth quarter. William Blair Investment Management LLC now owns 468,377 shares of the medical equipment provider’s stock worth $36,735,000 after purchasing an additional 192,956 shares during the last quarter. Assenagon Asset Management S.A. bought a new stake in shares of Integer during the second quarter worth $746,000. Finally, First National Bank of Omaha purchased a new stake in shares of Integer during the second quarter valued at $1,725,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.

Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.